Recalls / Active ingredient / Clomipramine Hydrochloride
Clomipramine Hydrochloride
6 FDA drug recalls involving the active ingredient “Clomipramine Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-10-22 | Class II | clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b) 90-co | Zydus Pharmaceuticals (USA) Inc |
| 2025-10-22 | Class II | clomiPRAMINE Hydrochloride, Capsules, USP, 50 mg, packaged in a) 30-count bottles (NDC 16714-850-01), b) 90-co | Zydus Pharmaceuticals (USA) Inc |
| 2025-10-22 | Class II | clomiPRAMINE Hydrochloride, Capsules, USP, 75 mg, packaged in a) 30-count bottles (NDC 16714-851-01), b) 90-co | Zydus Pharmaceuticals (USA) Inc |
| 2025-06-27 | Class II | clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naple | Lupin Pharmaceuticals Inc. |
| 2025-04-10 | Class II | clomiPRAMINE hydrochloride Capsules USP, 25 mg, 100-count bottle, Rx only, Manufactured For: Lupin Pharmaceuti | Lupin Pharmaceuticals Inc. |
| 2022-08-23 | Class III | ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Le | Leading Pharma, LLC |